[Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices]
- PMID: 6186585
[Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices]
Abstract
The present study was carried out to evaluate the inhibitory effect of oxatomide and disodium cromoglycate (DSCG) on the histamine release from rat PEC and lung slices induced by antigen-antibody reaction, concanavalin A, compound 48/80 and A-23187. Oxatomide in the range of 1 microM to 10 microM inhibited the allergic histamine release from rat PEC and lung slices induced by antigen-antibody reaction in the presence of phosphatidyl-L-serine (PS). Although the inhibitory action of oxatomide was significant even at a concentration of 1 microM, the action did not increase with an increase in concentration of the drug. DSCG showed a concentration-dependent inhibition on the allergic histamine release from rat PEC and lung slices in the range of 10 microM to 100 microM. The histamine release from rat PEC induced by the combined treatment of concanavalin A and PS was inhibited by oxatomide (0.1 to 10 microM) and DSCG (10 to 100 microM). Oxatomide (up to 10 microM) showed no effect on the histamine release induced by compound 48/80, while DSCG in the range of 10 microM to 100 microM showed a concentration dependent inhibition of the release. Oxatomide at a concentration of 10 microM showed a significant inhibition on the histamine release induced by the calcium ionophore A-23187. On the other hand, DSCG had no effect on this reaction. Oxatomide at high concentrations did not stimulate the histamine release by itself.
Similar articles
-
Comparative effects of oxatomide on the release of histamine from rat peritoneal mast cells.Agents Actions. 1981 May;11(3):184-92. doi: 10.1007/BF01967612. Agents Actions. 1981. PMID: 6167156
-
Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.Arerugi. 1992 Jun;41(6):676-85. Arerugi. 1992. PMID: 1280084
-
Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells.Int Arch Allergy Appl Immunol. 1987;83(4):348-53. doi: 10.1159/000234367. Int Arch Allergy Appl Immunol. 1987. PMID: 2440814
-
[Oxatomide: review of pharmacodynamic effects and clinical effects in dermatology].Allerg Immunol (Paris). 1990 Feb;22(2):61-9, 72. Allerg Immunol (Paris). 1990. PMID: 1690009 Review. French.
-
Antiinflammatory effects of oxatomide.J Investig Allergol Clin Immunol. 1999 Jul-Aug;9(4):207-14. J Investig Allergol Clin Immunol. 1999. PMID: 10513346 Review.
Cited by
-
Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.Agents Actions. 1987 Jun;21(1-2):32-7. doi: 10.1007/BF01974917. Agents Actions. 1987. PMID: 2442981
-
Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy.Drugs. 1984 Mar;27(3):210-31. doi: 10.2165/00003495-198427030-00003. Drugs. 1984. PMID: 6200290 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources